DAFTAR PUSTAKA

AHFS, 2011, AHFS Drug Information, Bethesda: American Society of Health System
Pharmacists.

Babitt JL, Lin HY. 2012. Mechanisms of Anemia in CKD. Journal of the American Society
of Nephrology, 23(10):1631–4.

Bansall and Chauhan, 2017. Management of type 2 Diabetes in patients with Chronic Kidney
Disease. Archives of Clinical Nephrology. 3(2): 047-052.

Batterink, J., Lin, J., Au-Yeung, S. H. M., & Cessford, T. (2015). Effectiveness of sodium
polystyrene sulfonate for short-term treatment of hyperkalemia. The Canadian journal
of hospital pharmacy, 68(4), 296.

Chi et al, 2009. Pain management in patients with chronic kidney disease. Nephrology
Dialysis Transplantation Plus. 2: 111–118

Cortés, D. O., Barros, T. G., Njimi, H., & Vincent, J. L. (2015). Crystalloids versus colloids:
exploring differences in fluid requirements by systematic review and meta-
regression. Anesthesia & Analgesia, 120(2), 389-402.

Dipiro et al, 2011, ParmacoteraphyA Pathophysiologic Approach, 9thed, USA: The McGraw
Hill Companies Inc.

Ghana, 2010. Standar Treatment Guidelines sixt Edition. Ministry of Health Republic of
Ghana

Harel, Z., Harel, S., Shah, P. S., Wald, R., Perl, J., & Bell, C. M. (2013). Gastrointestinal
adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic
review. The American journal of medicine, 126(3), 264-e9.

Haris, S danTambunan, T. 2009. HipertensipadaSindromMetabolik. Sari Pediatri, Vol. 11,

No. 4

Ismatullah, Ahmad. 2016. Manajemen Terapi Anemia pada Pasien Gagal Ginjal Kronik.
Fakultas Kedokteran. Universitas Lampung.
James et al, 2014. 2014 Evidence-Based Guideline for the Management of High Blood
Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint
National Committee (JNC 8)

KDIGO, 2012, Kidney International Supplements. Official Journal of The International

Society of Nephrology. Vol 2 Issue 4

KDOQI, 2015. Clinical Practice Guideline for Hemodialysis Adequacy. National Kidney
Foundation: USA

Khankin E V., Mutter WP, Tamez H, Yuan HT, Karumanchi SA, Thadhani R. 2010. Soluble
erythropoietin receptor contributes to erythropoietin resistance in end-stage renal
disease. PLoS One,5(2).

Lemes et al. 2011. Use of Small Doses Of Furosemide in Chronic Kidney Disease Patients
With Residual Renal Function Undergoing Hemodialysis. Clin Exp Nephrol. 15:554–
559

Medscape. 2019. www.medscape.com diakses pada tanggal 4 Mei 2019

Nemeth E, Ganz T. 2009. The role of hepcidin in iron metabolism. ActaHaematologica, Vol.
122.

Ono, T., Sanai, T., Miyahara, Y., & Noda, R. (2013). Olmesartan is more effective than other
angiotensin receptor antagonists in reducing proteinuria in patients with chronic
kidney disease other than diabetic nephropathy. Current Therapeutic Research, 74,
62-67.

Pierce, C. A., & Voss, B. (2010). Efficacy and safety of ibuprofen and acetaminophen in
children and adults: a meta-analysis and qualitative review. Annals of
Pharmacotherapy, 44(3), 489-506.

Restiyana Noor, 2015, Diabetes MelitusTipe 2. J Mayority. 5(4):93-101.

Saputra, Dedyanto Henky. 2017. Perkembangan Terapi Erythropoietin Stimulating Agent

untuk Anemia Penyakit Ginjal Kronik. Medical Department PT Kalbe Farma Tbk.
Jakarta, Indonesia

Singh, 2019, Ringer's Lactate. In StatPearls [Internet]. StatPearls Publishing.

Smorenberg, A., Ince, C., & Groeneveld, A. J. (2013). Dose and type of crystalloid fluid
therapy in adult hospitalized patients. Perioperative Medicine, 2(1), 17.

The Renal Association. 2017. Renal Association Clinical Practice Guideline – Anaemia of
Chronic Kidney Disease

Tsai et al, 2014. Association of Fluid Overload With Kidney Disease Progression
inAdvanced CKD: A Prospective Cohort Study. Am J Kidney Dis ;63(1):68-75

Viera, A. J., & Wouk, N. (2015). Potassium Disorders: Hypokalemia and

Hyperkalemia. American family physician, 92(6).

Wagner et al, 2016. Patient Safety Issues in CKD. Am J Kidney Dis. 66(1): 159–169.